Coriell Institute for Medical Research
Camden, New Jersey, 08103, United States
NCT Number: NCT01355224
This study will examine the impact of providing genetic risk information for obesity on people's attitudes and beliefs about obesity, health behaviors and weight outcomes. Specifically, this study will examine the feasibility of using genetic information to motivate efforts to reduce obesity among individuals recruited to the Coriell Personalized Medicine Collaborative (CPMC), see below for description of CPMC.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Camden, New Jersey, 08103, United States
The investigators will conduct a randomized controlled feasibility trial to examine the short-term impact of personalized risk feedback for obesity. This study is uniquely situated to provide important data on how individuals interpret various sources of risk information and how they arrive at an overall perception of risk for a condition. Taken altogether, study findings will be used to serve as an overall model for future intervention efforts to effectively communicate obesity risk information with the goal of improving weight management and overall population health.
CPMC-The CPMC is an ongoing evidence-based longitudinal research study designed to determine the utility of using personal genome information in health management and clinical decision-making. They collect saliva samples, perform genetic analysis and provide genetic risk feedback for several disease conditions including coronary artery disease and type 2 diabetes. The present study will build upon the existing genetic testing and web feedback infrastructure at Coriell to conduct behavioral science research to address critical public health questions.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Must be age 18 or older, active enrollees in the CPMC trial, and able to read and write in English.
Exclusion criteria
Individuals that do not meet the inclusion criteria.
Relative risk estimates will be presented based on individuals' risk for obesity based on FTO genotype results.
Other names: Genetic risk, Genetic risk feedback, FTO gene risk status
Relative risk estimates will be presented based on individuals' risk for obesity due to lifestyle factors.
Other names: Lifestyle risk, Lifestyle risk feedback
Time frame: 3 months after viewing obesity risk assessment
Intention to lose 10lbs in the next 6 months was measured on a 5-point likert scale (1-strongly disagree;5-strongly agree). Responses were examined by study arm.
Time frame: 3 months after viewing obesity risk assessment
Intention to lose 10lbs in the next 6 months measured on a 5-point likert scale (1-strongly disagree;5-strongly agree). This was examined by study arm and level of feedback received (high or elevated risk vs low or non-elevated risk).
Time frame: 3 months from viewing obesity risk assessment
Intention to lose 10lbs in the next 6 months on a 5-point likert scale (1-strongly disagree; 5-strongly agree). This was examined by study arm and by combined levels of feedback (e.g. elevated genetic risk and non-elevated lifestyle risk)
Boston University
Other
Communicating Genetic Information for Obesity
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02329262
Adherence Interventions, Behavior
Bidwell, Ohio, United States
View Trial DetailsNCT05249465
Behavior, Body Weight
Stanford, California, United States
View Trial DetailsNCT03880838
Behavior, Body Weight
Danville, Pennsylvania, United States
View Trial DetailsNCT05715242
Behavior, Body Weight
Palo Alto, California, United States
View Trial Details